Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
The Washington University has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, indicating separate examination paths across the portfolio.
MYERS, CARLA J is the busiest examiner and handles 1 pending matter. Prosecution management should combine centralized coordination with responses tailored to each examiner and art unit.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| §103 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAGUIO FRISING, MICHELLE F | 1 | 71.2% | +38.9% |
| MARCETICH, ADAM M | 1 | 72.8% | +18.8% |
| MYERS, CARLA J | 1 | 49.5% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | MYERS, CARLA J | 30d overdue |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | PAGUIO FRISING, MICHELLE F | 22d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | MYERS, CARLA J | 30d overdue |
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | PAGUIO FRISING, MICHELLE F | 22d |
| 17947881 | DUAL PORT DRAIN | MARCETICH, ADAM M | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 3781 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17947861 | METHODS FOR DISEASE ASSESSMENT USING DRAIN FLUID | PAGUIO FRISING, MICHELLE F | 1651 | §101DP | Non-Final OA | 22d | Pending | Sep 19, 2022 |
| 17947881 | DUAL PORT DRAIN | MARCETICH, ADAM M | 3781 | §103 | Non-Final OA | — | Pending | Sep 19, 2022 |
| 17947871 | LYMPHATIC FLUID FOR DIAGNOSTICS | MYERS, CARLA J | 1682 | §101§103§112DP | Final Rejection | 30d overdue | Pending | Sep 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Washington University has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Michelle F Paguio Frising has the most, with 1 of The Washington University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
